Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

Celgene Corporation (CELG) 123.64 0.20
Price Open:121.95Day's Range:71.20450 - 131.79900
Price Close:123.4452wk Range:58.53 - 131.79900
Price Day Change:0.20Volume:2,362,474
Price % Change:0.16Market Cap:51.573B
Bid:123.75000PE Ratio:37.55
Ask:123.95000EPS Diluted:3.287
Trade CELG NOW!

The Latest On CELG

Celgene Announces FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer 5/23/13 7:34am
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter 5/15/13 4:13am
Short Interest in Vertex Rises, in Celgene Falls 5/11/13 10:45am
S&P Highlights Biotech ETFs 5/10/13 7:39am
UPDATE: Celgene's Says Apremilast Achieves Statistical Significant for Primary, Major Secondary Endpoints in Fourth Pivotal Phase III Study 5/6/13 2:29pm
Concert Pharma Reports Strategic Collaboration with Celgene 5/6/13 7:11am
Three Sector ETFs Up 20% or More YTD 5/3/13 8:09am
Illumina and Other Bargain Biotech Stocks Worth a Look Now 5/1/13 12:57pm
FORMA, Celgene Announce Strategic Collaboration for Discovery, Development, Commercialization of Protein Homeostasis Targets 4/29/13 7:55am
Short Sellers Move into Celgene, Regeneron 4/26/13 1:25pm
Celgene's REVLIMID Wins Positive CHMP Opinion 4/26/13 7:30am
Amgen Earnings Preview: Strong Earnings Growth Expected 4/22/13 1:15pm
more
Press Releases
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer 5/23/13 Business Wire
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer 5/23/13 Business Wire
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer 5/23/13 Business Wire
Critical Alerts For Yahoo!, Celgene, Brinker International, Qlik Technologies, and Beam Released By InvestorsObserver 5/13/13 Newswire
Acceleron's ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes 5/10/13 Business Wire
NeoStem CEO's Letter to Shareholders 5/9/13 GlobeNewswire
Apremilast Achieves Statistical Significance for the Primary and Major Secondary Endpoints in Fourth Pivotal Phase III Study (PALACE 4) of Patients with Psoriatic Arthritis 5/6/13 Business Wire
Celgene Corporation to Webcast at Upcoming Investor Conferences and Analyst Day 4/29/13 Business Wire
Celgene Reports First Quarter 2013 Operating and Financial Results 4/25/13 Business Wire
Critical Trade Alerts For GE, Celgene, MetroPCS Communications, Nu Skin Enterprises, and Arris Released By InvestorsObserver 4/11/13 Newswire
The Vatican's Pontifical Council for Culture, NeoStem, The Stem for Life Foundation & STOQ International Host 2nd International Vatican Adult Stem Cell Conference 4/11/13 GlobeNewswire
Celgene Corporation to Announce First Quarter 2013 Results on April 25, 2013 4/3/13 Business Wire

Get the latest CELG stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Celgene Corporation stock price.

Partner Headlines
NPS Pharma Prices Offering - Analyst Blog 5/23/13
Encouraging News for Peregrine Pharma - Analyst Blog 5/23/13
Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rally 5/22/13
Gilead's Sofosbuvir under European Review - Analyst Blog 5/22/13
Stocks Reverse Lower On Fears That Fed May Pare Easing 5/22/13
Stocks Stage Broad Advance; Bristol-Myers Leads Medicals 5/22/13
Stocks Fade Late On Data, Fed 5/16/13
Stocks Close Lower; Dell Little Changed After Earnings 5/16/13
Wall Street Turns Down At The Bell; Celgene Sells Off 5/16/13
Gilead Drug For Leukemia Shows Success In Early Trial 5/16/13
Stocks Flat In Late Trading, But Cisco Lifts Nasdaq 5/16/13
NASDAQ 100 Mid-day Update: Higher Top Performers: CSCO, NTAP, FFIV 5/16/13